Gapping up
In reaction to earnings/guidance:
- CVAC +6.9% (also provides vaccine update), OGI +5.3%, GLW +2.7% (guidance update) ADNT +2.5%, CRSR +2.1%
M&A news:
- NGA +19.7% (Northern Genesis Acquisition Corp and The Lion Electric Company announce merger and commitments for $200 million in a PIPE; combined company expected to be listed on NYSE)
- INFO +5.3% (S&P Global (SPGI) and IHS Markit (INFO) to merge in an all-stock transaction which values IHS Markit at an enterprise value of $44 billion)
- AEG +3% (divests its Central and Eastern European business to VIG for EUR830 mln)
Other news:
- CAAS +30.5% (has shipped approximately 120,000 units from its portfolio of electric power steering products for use in Chinese electric vehicles during 2020)
- AUTL +15.4% (announces publication of new AUTO6 Phase 1 data in childhood neuroblastoma in Science Translational Medicine)
- MRNA +10.9% (announces primary efficacy analysis in Phase 3 COVE study for COVID-19 vaccine candidate and filing today with U.S. FDA for Emergency Use Authorization; Vaccine efficacy against COVID-19 was 94.1%; also amends supply agreement with UK for additional two million doses of COVID-19 vaccine)
- VERI +5.6% (Veritone aiWARE now supports NVIDIA (NVDA) CUDA for GPU-based AI and machine learning)
- MCF +5.5% (Contango Oil & Gas announces signing of agreement to acquire Oily, low decline assets in Big Horn, Permian, and Powder River Basins)
- OTIC +2.4% (provides update on OTIVIDEX and OTO-313 programs)
- PLUG +2.1% (to collaborate with Gaussin on hydrogen-powered transportation vehicles)
- SHOP +1.7% (reports Black Friday sales increased 75% yr/yr to $2.4 bln)
- AZN +1.7% (receives approval in Japan for Forxiga)
- BCRX +1.4% (Allergy publishes results from BioCryst's APeX-J trial of oral, once-daily Berotralstat for the Prevention of HAE Attacks)
- APDN +1% (Applied DNA Sciences DNA, EvviVax, and GVS receive regulatory approval to conduct veterinary clinical trial for linear COVID-19 vaccine candidate)